-
Varenicline promotes endothelial cell migration by lowering vascular endothelial-cadherin levels via the activated α7 nicotinic acetylcholine receptor-mitogen activated protein kinase axis.
Toxicology 20170901
-
Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α(7) nAChR in macrophages.
Toxicology 20170401
-
Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Chemical research in toxicology 20150518
-
Organic cation transporter variation and response to smoking cessation therapies.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20141201
-
Comparative pathophysiology, toxicology, and human cancer risk assessment of pharmaceutical-induced hibernoma.
Toxicology and applied pharmacology 20131215
-
Effects of nicotinic acetylcholine receptor agonists on cognition in rhesus monkeys with a chronic cocaine self-administration history.
Neuropharmacology 20130101
-
The effect of smoking cessation pharmacotherapies on pancreatic beta cell function.
Toxicology and applied pharmacology 20121115
-
Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors.
Neuropharmacology 20121101
-
Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain.
The Journal of pharmacology and experimental therapeutics 20121101
-
Strategies to help a smoker who is struggling to quit.
JAMA 20121017
-
An economic evaluation based on a randomized placebo-controlled trial of varenicline in smokers with cardiovascular disease: results for Belgium, Spain, Portugal, and Italy.
European journal of preventive cardiology 20121001
-
Varenicline decreases nicotine self-administration and cue-induced reinstatement of nicotine-seeking behaviour in rats when a long pretreatment time is used.
The international journal of neuropsychopharmacology 20121001
-
Project Impact: a pharmacotherapy pilot trial investigating the abstinence and treatment adherence of Latino light smokers.
Journal of substance abuse treatment 20121001
-
Varenicline induced psychosis in schizophrenia.
The Australian and New Zealand journal of psychiatry 20121001
-
Varenicline decreases alcohol consumption in heavy-drinking smokers.
Psychopharmacology 20121001
-
Effects of 21 days of varenicline versus placebo on smoking behaviors and urges among non-treatment seeking smokers.
Journal of psychopharmacology (Oxford, England) 20121001
-
Adverse neuropsychiatric events associated with varenicline use in veterans: a case series.
Issues in mental health nursing 20121001
-
Characteristics of COPD smokers and effectiveness and safety of smoking cessation medications.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120901
-
Adherence to varenicline among African American smokers: an exploratory analysis comparing plasma concentration, pill count, and self-report.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120901
-
Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats.
Psychopharmacology 20120901
-
Impact of varenicline on cue-specific craving assessed in the natural environment among treatment-seeking smokers.
Psychopharmacology 20120901
-
The effects of varenicline on attention and inhibitory control among treatment-seeking smokers.
Psychopharmacology 20120901
-
Use of an α3β4 nicotinic acetylcholine receptor subunit concatamer to characterize ganglionic receptor subtypes with specific subunit composition reveals species-specific pharmacologic properties.
Neuropharmacology 20120901
-
The antinociceptive effects of nicotinic partial agonists varenicline and sazetidine-A in murine acute and tonic pain models.
The Journal of pharmacology and experimental therapeutics 20120901
-
Comparisons of high-dose and combination nicotine replacement therapy, varenicline, and bupropion for smoking cessation: a systematic review and multiple treatment meta-analysis.
Annals of medicine 20120901
-
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes.
The pharmacogenomics journal 20120801
-
Varenicline is a potent partial agonist at α6β2* nicotinic acetylcholine receptors in rat and monkey striatum.
The Journal of pharmacology and experimental therapeutics 20120801
-
Do package inserts reflect symptoms experienced in practice?: assessment using an automated phone pharmacovigilance system with varenicline and zolpidem in a primary care setting.
Drug safety 20120801
-
Efficacy and safety of pharmacotherapy for smoking cessation among pregnant smokers: a meta-analysis.
BJOG : an international journal of obstetrics and gynaecology 20120801
-
Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
Clinical therapeutics 20120801
-
Health impact of smoking and smoking cessation strategies: current evidence.
British journal of community nursing 20120801
-
Does varenicline worsen psychiatric symptoms in patients with schizophrenia or schizoaffective disorder? A review of published studies.
The Journal of clinical psychiatry 20120801
-
Structural characterization of binding mode of smoking cessation drugs to nicotinic acetylcholine receptors through study of ligand complexes with acetylcholine-binding protein.
The Journal of biological chemistry 20120706
-
Prescribing of nicotine replacement therapy to cardiovascular disease patients in England.
Addiction (Abingdon, England) 20120701
-
Varenicline increases in vivo striatal dopamine D2/3 receptor binding: an ultra-high-resolution pinhole [123I]IBZM SPECT study in rats.
Nuclear medicine and biology 20120701
-
Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: a case series from two national pharmacovigilance centres.
European journal of clinical pharmacology 20120701
-
Effectiveness of varenicline for smoking cessation at 2 urban academic health centers.
European journal of internal medicine 20120701
-
Varenicline blocks β2*-nAChR-mediated response and activates β4*-nAChR-mediated responses in mice in vivo.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120601
-
A single administration of low-dose varenicline saturates α4β2* nicotinic acetylcholine receptors in the human brain.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120601
-
Pharmacologic characterization of a nicotine-discriminative stimulus in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 20120601
-
A pilot test of a combined tobacco dependence treatment and lung cancer screening program.
Lung cancer (Amsterdam, Netherlands) 20120501
-
Very low rate and light smokers: smoking patterns and cessation-related behaviour in England, 2006-11.
Addiction (Abingdon, England) 20120501
-
Varenicline potentiates alcohol-induced negative subjective responses and offsets impaired eye movements.
Alcoholism, clinical and experimental research 20120501
-
[Effectiveness and safety of varenicline for smoking cessation].
Deutsche medizinische Wochenschrift (1946) 20120501
-
A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
The Journal of clinical psychiatry 20120501
-
Nicotine receptor partial agonists for smoking cessation.
The Cochrane database of systematic reviews 20120418
-
Changes in health-related quality of life with smoking cessation treatment.
European journal of public health 20120401
-
Plasma levels of metabolites of catecholamine in nicotine-dependent patients treated with varenicline.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120401
-
Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.
Paediatric drugs 20120401
-
Promoting smoking cessation.
American family physician 20120315
-
Cost-effectiveness of tobacco control policies in Vietnam: the case of personal smoking cessation support.
Addiction (Abingdon, England) 20120301
-
Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120301
-
A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120301
-
Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline.
Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology 20120301
-
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3.
Neurology 20120221
-
Pfizer advertises smoking cessation drug despite health warnings.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20120207
-
Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20120201
-
Results of an initial clinical trial of varenicline for the treatment of cocaine dependence.
Drug and alcohol dependence 20120201
-
Effects of varenicline and bupropion on cognitive processes among nicotine-deprived smokers.
Experimental and clinical psychopharmacology 20120201
-
Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201
-
Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20120201
-
The effects of extended pre-quit varenicline treatment on smoking behavior and short-term abstinence: a randomized clinical trial.
Clinical pharmacology and therapeutics 20120201
-
Quitting smoking with varenicline: parallel, randomised efficacy trial in Iran.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 20120201
-
Grover disease may result from the impairment of keratinocytic cholinergic receptors.
Journal of the American Academy of Dermatology 20120201
-
Systematic review of the cost-effectiveness of varenicline vs. bupropion for smoking cessation.
International journal of clinical practice 20120201
-
Cost-effectiveness analysis of varenicline versus existing smoking cessation strategies in Central America and the Caribbean using the BENESCO model.
Hospital practice (1995) 20120201
-
Cost analysis of varenicline versus bupropion, nicotine replacement therapy, and unaided cessation in Nicaragua.
Hospital practice (1995) 20120201
-
Varenicline: aggression and homicidal ideation.
Prescrire international 20120201
-
The pain of giving up smoking.
International journal of cardiology 20120126
-
[Smoking cessation in medical practice--new possibilities?].
Revue medicale suisse 20120125
-
New reports examine psychiatric risks of varenicline for smoking cessation.
JAMA 20120111
-
Varenicline as a smoking cessation aid in schizophrenia: effects on smoking behavior and reward sensitivity.
Psychopharmacology 20120101
-
Safety and tolerability of varenicline tartrate (Champix(®)/Chantix(®)) for smoking cessation in HIV-infected subjects: a pilot open-label study.
AIDS patient care and STDs 20120101
-
Cardiovascular events in patients taking varenicline: a case series from intensive postmarketing surveillance in New Zealand.
Drug safety 20120101
-
Varenicline precipitating psychosis in a patient with no previous psychiatric history: a case report of a Spanish patient who was later diagnosed with paranoid personality disorder.
Clinical schizophrenia & related psychoses 20120101
-
Real world evaluation of three models of NHS smoking cessation service in England.
BMC research notes 20120101
-
Varenicline in stopping long-term nicotine use.
The American journal on addictions 20120101
-
Varenicline.
Profiles of drug substances, excipients, and related methodology 20120101
-
Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-analysis.
BMJ (Clinical research ed.) 20120101
-
Drug-induced liver injury due to varenicline: a case report.
BMC gastroenterology 20120101
-
Economic impact of delays in listing decisions by provincial drug plans after a positive Common Drug Review recommendation: the case of a smoking-cessation treatment.
Healthcare quarterly (Toronto, Ont.) 20120101
-
Use of the Patient Health Questionnaire-2 to predict suicidal ideations in patients taking varenicline.
The American journal on addictions 20120101
-
A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial.
Health communication 20111201
-
Effects of moderate-dose treatment with varenicline on neurobiological and cognitive biomarkers in smokers and nonsmokers with schizophrenia or schizoaffective disorder.
Archives of general psychiatry 20111201
-
Tobacco dependence treatment for hospitalized smokers: a randomized, controlled, pilot trial using varenicline.
Addictive behaviors 20111201
-
Efficacy of a flexible quit date versus an a priori quit date approach to smoking cessation: a cross-study analysis.
Addictive behaviors 20111201
-
A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
Expert opinion on pharmacotherapy 20111201
-
[The evaluation of strengthened psychological and behavioral intervention in smoking cessation clinics].
Zhonghua nei ke za zhi 20111201
-
Varenicline prevents affective and cognitive exacerbation during smoking abstinence in male patients with schizophrenia.
Psychiatry research 20111130
-
Quantification of nicotine, cotinine, trans-3'-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC-tandem mass-spectrometry procedure for a clinical study on smoking cessation.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20111115
-
Unichiral 2-(2'-pyrrolidinyl)-1,4-benzodioxanes: the 2R,2'S diastereomer of the N-methyl-7-hydroxy analogue is a potent α4β2- and α6β2-nicotinic acetylcholine receptor partial agonist.
Journal of medicinal chemistry 20111110
-
Varenicline effects on craving, cue reactivity, and smoking reward.
Psychopharmacology 20111101
-
Lung function and respiratory symptoms in a 1-year randomized smoking cessation trial of varenicline in COPD patients.
Respiratory medicine 20111101
-
The smoking cessation drug varenicline improves deficient P20-N40 inhibition in DBA/2 mice.
Pharmacology, biochemistry, and behavior 20111101
-
Effects of varenicline on the reinforcing and discriminative stimulus effects of cocaine in rhesus monkeys.
The Journal of pharmacology and experimental therapeutics 20111101
-
[Good effect of varenicline in snuff use cessation. Double-blind placebo controlled comparative study].
Lakartidningen 20111101
-
The effect of varenicline on heart rate variability in healthy smokers and nonsmokers.
Autonomic neuroscience : basic & clinical 20111028
-
Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Addiction (Abingdon, England) 20111001
-
The impact of the introduction of smoke-free legislation on prescribing of stop-smoking medications in England.
Addiction (Abingdon, England) 20111001
-
Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20111001
-
Patterns of nicotinic receptor antagonism: nicotine discrimination studies.
The Journal of pharmacology and experimental therapeutics 20111001
-
Varenicline is a potent agonist of the human 5-hydroxytryptamine3 receptor.
The Journal of pharmacology and experimental therapeutics 20111001
-
Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
Current medical research and opinion 20111001
-
Nicotine receptor partial agonists for smoking cessation.
American family physician 20111001
-
More evidence that varenicline harms the heart.
The Harvard mental health letter 20111001
-
A comparison of brain and behavioral effects of varenicline and nicotine in rats.
Behavioural brain research 20110930
-
Clinical practice. Treating smokers in the health care setting.
The New England journal of medicine 20110929
-
Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
Varenicline for smoking cessation: is it a heartbreaker?
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
Varenicline: quantifying the risk.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
Varenicline: quantifying the risk.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
Varenicline: quantifying the risk.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
Varenicline: quantifying the risk.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
Varenicline: quantifying the risk.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
Varenicline: cardiovascular safety.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110906
-
[Abstinence rates with varenicline compared to bupropion and nicotine replacement therapy for quitting smoking in primary care].
Atencion primaria 20110901
-
Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380.
Psychopharmacology 20110901
-
A pilot clinical trial of varenicline for smoking cessation in black smokers.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110901
-
A pilot study of the efficacy of varenicline for the treatment of smokeless tobacco users in Midwestern United States.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110901
-
Did the introduction of varenicline in England substitute for or add to the use of other smoking cessation medications?
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110901
-
Psychiatric adverse events associated with varenicline: an intensive postmarketing prospective cohort study in New Zealand.
Drug safety 20110901
-
In brief: Cardiovascular safety of varenicline (Chantix).
The Medical letter on drugs and therapeutics 20110822
-
Varenicline for tobacco dependence: panacea or plight?
Expert opinion on pharmacotherapy 20110801
-
[Clinical study of smoking cessation clinic subjects].
Nihon Jibiinkoka Gakkai kaiho 20110801
-
Varenicline attenuates cue-induced relapse to alcohol, but not nicotine seeking, while reducing inhibitory response control.
Psychopharmacology 20110701
-
Effectiveness of varenicline for smoking cessation: a 1-year follow-up study.
Journal of substance abuse treatment 20110701
-
Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.
Addiction biology 20110701
-
Prescribing of smoking cessation medication in England since the introduction of varenicline.
Addiction (Abingdon, England) 20110701
-
The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of β2 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors.
Neuropharmacology 20110601
-
A preliminary investigation of varenicline for heavy drinking smokers.
Psychopharmacology 20110601
-
A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
Biological psychiatry 20110601
-
Selective α4β2 nicotinic acetylcholine receptor agonists target epigenetic mechanisms in cortical GABAergic neurons.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110601
-
Varenicline for smoking cessation in people with schizophrenia: a double blind randomized pilot study.
Schizophrenia research 20110601
-
Varenicline induced mania in a 51 year old patient without history of bipolar illness.
Progress in neuro-psychopharmacology & biological psychiatry 20110601
-
A discrete-event simulation of smoking-cessation strategies based on varenicline pivotal trial data.
PharmacoEconomics 20110601
-
A case of late-life onset mania during Varenicline assisted smoking cessation.
International journal of geriatric psychiatry 20110601
-
A smoking cessation intervention for thoracic surgery and oncology clinics: a pilot trial.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20110601
-
Varenicline and the evaluation of neuropsychiatric adverse events in smokers.
Biological psychiatry 20110601
-
Core modification of cytisine: a modular synthesis.
Angewandte Chemie (International ed. in English) 20110523
-
Effects of varenicline on smoking cue–triggered neural and craving responses.
Archives of general psychiatry 20110501
-
Nicotinic receptor agonists decrease L-dopa-induced dyskinesias most effectively in partially lesioned parkinsonian rats.
Neuropharmacology 20110501
-
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
The Journal of pharmacology and experimental therapeutics 20110501
-
Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110501
-
Adherence to varenicline in the COMPASS smoking cessation intervention trial.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110501
-
Treatment of nicotine dependence with Chantix (varenicline).
Texas dental journal 20110501
-
Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates.
Archives of internal medicine 20110425
-
Smoking cessation interventions: a primer for physicians: Comment on 'Use of varenicline for 4 weeks before quitting smoking'.
Archives of internal medicine 20110425
-
[Smoking cessation--assistance for the general practitioner].
MMW Fortschritte der Medizin 20110407
-
Pharmacokinetics, safety, and tolerability following multiple oral doses of varenicline under various titration schedules in elderly nonsmokers.
Journal of clinical pharmacology 20110401
-
Single- and multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy Japanese adult smokers.
Journal of clinical pharmacology 20110401
-
A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities.
Journal of evaluation in clinical practice 20110401
-
Effectiveness of varenicline as an aid to smoking cessation: results of an inter-European observational study.
Current medical research and opinion 20110401
-
What justifies a placebo-controlled trial of Varenicline for smoking cessation in patients with COPD?
Chest 20110401
-
Effects of varenicline in adult smokers: a multinational, 24-week, randomized, double-blind, placebo-controlled study.
Clinical therapeutics 20110401
-
Smoking cessation pharmacotherapy: a concise overview.
Advance for NPs & PAs 20110401
-
Breaking free from nicotine dependence. A combination of strategies boosts the odds of success.
The Harvard mental health letter 20110401
-
Clinical shorts.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20110322
-
Synthesis of 2-(substituted phenyl)-3,5,5-trimethylmorpholine analogues and their effects on monoamine uptake, nicotinic acetylcholine receptor function, and behavioral effects of nicotine.
Journal of medicinal chemistry 20110310
-
Effects of varenicline on smoking cessation in patients with mild to moderate COPD: a randomized controlled trial.
Chest 20110301
-
Abstinence and psychological distress in co-morbid smokers using various pharmacotherapies.
Drug and alcohol dependence 20110301
-
The effects of nicotine, varenicline, and cytisine on schedule-controlled responding in mice: differences in α4β2 nicotinic receptor activation.
European journal of pharmacology 20110301
-
Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy.
Primary care 20110301
-
Interventions for smokeless tobacco use cessation.
The Cochrane database of systematic reviews 20110216
-
Nicotine receptor partial agonists for smoking cessation.
The Cochrane database of systematic reviews 20110216
-
Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration.
Psychopharmacology 20110201
-
Dose-dependent and sustained effects of varenicline on dopamine D2/3 receptor availability in rats.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20110201
-
Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110201
-
Australia's experience with varenicline: usage, costs and adverse reactions.
Addiction (Abingdon, England) 20110201
-
Adynamic ileus induced by varenicline.
Current drug safety 20110201
-
Integrating results from smoking cessation drug research and development into clinical occupational health practice.
AAOHN journal : official journal of the American Association of Occupational Health Nurses 20110201
-
Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims.
Clinical therapeutics 20110201
-
[Pharmacotherapies for nicotine dependence: review of scientific evidence. Spanish Society of Smoking Specialists: recommendations about election and individualization].
Medicina clinica 20110129
-
Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.
Journal of substance abuse treatment 20110101
-
Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
Neurochemistry international 20110101
-
Parallel anxiolytic-like effects and upregulation of neuronal nicotinic acetylcholine receptors following chronic nicotine and varenicline.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20110101
-
Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
Current medicinal chemistry 20110101
-
Functional interactions of fibrillar and oligomeric amyloid-β with alpha7 nicotinic receptors in Alzheimer's disease.
Journal of Alzheimer's disease : JAD 20110101
-
Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.
The American journal on addictions 20110101
-
Nicotinic acetylcholine receptors containing the α4 subunit are critical for the nicotine-induced reduction of acute voluntary ethanol consumption.
Channels (Austin, Tex.) 20110101
-
Pharmacotherapy for smoking.
Canadian family physician Medecin de famille canadien 20110101
-
Usage patterns of stop smoking medications in Australia, Canada, the United Kingdom, and the United States: findings from the 2006-2008 International Tobacco Control (ITC) Four Country Survey.
International journal of environmental research and public health 20110101
-
Correlation between willing to smoking cessation and treatment outcome of health care workers in Thailandt.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20110101
-
Pharmacotherapy for smoking cessation: present and future.
Current pharmaceutical design 20110101
-
Culturally-tailored smoking cessation for American Indians: study protocol for a randomized controlled trial.
Trials 20110101
-
A manic episode in a 64-year-old man: an adverse effect of varenicline.
General hospital psychiatry 20110101
-
The management of tobacco smoking.
Cardiovascular journal of Africa 20110101
-
Varenicline induces manic relapse in bipolar disorder.
General hospital psychiatry 20110101
-
Gastrointestinal adverse effects of varenicline at maintenance dose: a meta-analysis.
BMC clinical pharmacology 20110101
-
Suicidal behavior and depression in smoking cessation treatments.
PloS one 20110101
-
Effects of smoking cessation on central blood pressure and arterial stiffness.
Vascular health and risk management 20110101
-
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.
Drugs 20101224
-
Nicotine receptor partial agonists for smoking cessation.
The Cochrane database of systematic reviews 20101208
-
Drug treatment for users of smokeless tobacco.
BMJ (Clinical research ed.) 20101206
-
The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats.
Progress in neuro-psychopharmacology & biological psychiatry 20101201
-
Drug discrimination in methamphetamine-trained rats: effects of cholinergic nicotinic compounds.
The Journal of pharmacology and experimental therapeutics 20101201
-
The nicotinic acetylcholine receptor partial agonist varenicline increases the ataxic and sedative-hypnotic effects of acute ethanol administration in C57BL/6J mice.
Alcoholism, clinical and experimental research 20101201
-
Nicotine receptors and depression: revisiting and revising the cholinergic hypothesis.
Trends in pharmacological sciences 20101201
-
A review of the clinical pharmacokinetics and pharmacodynamics of varenicline for smoking cessation.
Clinical pharmacokinetics 20101201
-
Varenicline-induced grand mal seizure.
Epileptic disorders : international epilepsy journal with videotape 20101201
-
Thiopurine S-methyltransferase deficiency associated with a novel mutation.
Inflammatory bowel diseases 20101101
-
Immediate versus delayed quitting and rates of relapse among smokers treated successfully with varenicline, bupropion SR or placebo.
Addiction (Abingdon, England) 20101101
-
Mental health stability in veterans with posttraumatic stress disorder receiving varenicline.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20101101
-
[Sustainable efficacy of oral varenicline for smoking cessation].
Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society 20101101
-
Comparison of available treatments for tobacco addiction.
Current psychiatry reports 20101001
-
A pilot study to assess smokeless tobacco use reduction with varenicline.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20101001
-
Nicotine gum dependence treated with varenicline--a case report.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20101001
-
Clinical experience of varenicline for smoking cessation.
The clinical respiratory journal 20101001
-
A brief review of pharmacotherapeutic treatment options in smoking cessation: bupropion versus varenicline.
Journal of the American Academy of Nurse Practitioners 20101001
-
Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Health technology assessment (Winchester, England) 20101001
-
Varenicline (champix)-associated manic relapse in bipolar affective disorder.
Irish medical journal 20101001
-
Utilization of the smoking cessation medicine varenicline: an intensive post-marketing study in New Zealand.
Pharmacoepidemiology and drug safety 20100901
-
Thoughts and acts of aggression/violence toward others reported in association with varenicline.
The Annals of pharmacotherapy 20100901
-
Varenicline treatment for smoking cessation in Asian populations: a pooled analysis of placebo-controlled trials conducted in six Asian countries.
Current medical research and opinion 20100901
-
The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study.
The American journal on addictions 20100901
-
Pharmacoeconomic spotlight on varenicline as an aid to smoking cessation.
CNS drugs 20100901
-
Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.
The American journal of managed care 20100901
-
Electroconvulsive therapy (ECT) effective for psychotic recrudescence and suicidality after varenicline adjunctive therapy for smoking cessation in a schizoaffective patient.
Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 20100901
-
Letter by Smolderen and Pelle regarding article, 'Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial'.
Circulation 20100831
-
Drug safety crackdown revs up.
Nature 20100805
-
Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior.
The Journal of pharmacology and experimental therapeutics 20100801
-
Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice.
Pharmacology, biochemistry, and behavior 20100801
-
Smoking cessation-recent advances.
Cardiovascular drugs and therapy 20100801
-
The use of snus for quitting smoking compared with medicinal products.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100801
-
[The management of patients with nicotine dependence - the role of the general practitioners].
Therapeutische Umschau. Revue therapeutique 20100801
-
[Medical therapy for smoking cessation].
Therapeutische Umschau. Revue therapeutique 20100801
-
[Preventive relapse treatment for tobacco cessation - is it worthwhile?].
Therapeutische Umschau. Revue therapeutique 20100801
-
Activation of alpha4* nAChRs is necessary and sufficient for varenicline-induced reduction of alcohol consumption.
The Journal of neuroscience : the official journal of the Society for Neuroscience 20100728
-
Cross-validation of a new procedure for early screening of smoking cessation medications in humans.
Clinical pharmacology and therapeutics 20100701
-
Varenicline-induced drug eruption with resulting palmar/plantar hyperhidrosis and dysesthesia.
Journal of the American Academy of Dermatology 20100701
-
Predictors of post-treatment relapse to smoking in successful quitters: pooled data from two phase III varenicline trials.
Drug and alcohol dependence 20100601
-
Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia.
Schizophrenia research 20100601
-
Extinction with varenicline and nornicotine, but not ABT-418, weakens conditioned responding evoked by the interoceptive stimulus effects of nicotine.
Neuropharmacology 20100601
-
Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.
Schizophrenia research 20100601
-
Smoking outcome by psychiatric history after behavioral and varenicline treatment.
Journal of substance abuse treatment 20100601
-
Characteristics and abstinence outcomes among tobacco quitline enrollees using varenicline or nicotine replacement therapy.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100601
-
Mouse model predicts effects of smoking and varenicline on event-related potentials in humans.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100601
-
Adherence to treatment for tobacco dependence: association with smoking abstinence and predictors of adherence.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20100601
-
Varenicline withdrawal-induced delirium with psychosis.
The American journal of psychiatry 20100601
-
Varenicline in smoking cessation.
Expert review of respiratory medicine 20100601
-
Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.
The Journal of pharmacology and experimental therapeutics 20100501
-
Varenicline use in patients with mental illness: an update of the evidence.
Expert opinion on drug safety 20100501
-
Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence.
Psychopharmacology 20100501
-
Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence.
British journal of pharmacology 20100501
-
Behavioral counseling and varenicline treatment for smoking cessation.
American journal of preventive medicine 20100501
-
[Pharmacological profile and clinical findings on varenicline tartrate (Champix tablets)].
Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20100501
-
Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
Biological psychiatry 20100415
-
Evaluation of varenicline as an aid to smoking cessation in UK general practice - a THIN database study.
Current medical research and opinion 20100401
-
A randomized controlled open comparative trial of varenicline vs nicotine patch in adult smokers: efficacy, safety and withdrawal symptoms (the VN-SEESAW study).
Circulation journal : official journal of the Japanese Circulation Society 20100401
-
Pharmacological effects of nonselective and subtype-selective nicotinic acetylcholine receptor agonists in animal models of persistent pain.
Pain 20100401
-
Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats.
Naunyn-Schmiedeberg's archives of pharmacology 20100401
-
Psychiatric adverse events in randomized, double-blind, placebo-controlled clinical trials of varenicline: a pooled analysis.
Drug safety 20100401
-
Varenicline does not increase serum BDNF levels in patients with nicotine dependence.
Human psychopharmacology 20100401
-
Synthesis, nicotinic acetylcholine receptor binding, and antinociceptive properties of 3'-(substituted phenyl)epibatidine analogues. Nicotinic partial agonists.
Journal of natural products 20100326
-
Varenicline and pheochromocytoma.
Annals of internal medicine 20100302
-
Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
Current medical research and opinion 20100301
-
Modulation of ethanol consumption by genetic and pharmacological manipulation of nicotinic acetylcholine receptors in mice.
Psychopharmacology 20100301
-
Varenicline effects on cocaine self administration and reinstatement behavior.
Behavioural pharmacology 20100301
-
Quantitative assessment of exposure-response relationships for the efficacy and tolerability of varenicline for smoking cessation.
Clinical pharmacology and therapeutics 20100301
-
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
CNS & neurological disorders drug targets 20100301
-
Smoking cessation intervention: an evidence-based approach.
Postgraduate medicine 20100301
-
Integrating smoking cessation into HIV care.
AIDS patient care and STDs 20100301
-
Rapid and sustained response to a single dose of sertraline in a patient with newly emergent depression during varenicline-assisted smoking cessation.
CNS spectrums 20100301
-
Effect of the alpha4beta2* nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area.
Neuropharmacology 20100201
-
The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20100201
-
The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats.
Psychopharmacology 20100201
-
Current approaches to pharmacotherapy for smoking cessation.
Therapeutic advances in respiratory disease 20100201
-
Improving the effectiveness of tobacco use cessation (TUC).
International dental journal 20100201
-
Current treatment options in smoking cessation.
Hospital practice (1995) 20100201
-
Varenicline and P50 auditory gating in medicated schizophrenic patients: a pilot study.
Psychiatry research 20100130
-
Varenicline for smoking cessation in patients with coronary heart disease.
Circulation 20100119
-
Efficacy and safety of varenicline for smoking cessation in patients with cardiovascular disease: a randomized trial.
Circulation 20100119
-
Pharmacogenetics of smoking cessation therapy.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 20100105
-
Working memory deficits predict short-term smoking resumption following brief abstinence.
Drug and alcohol dependence 20100101
-
[Tolerability profile of varenicline in current medical practice].
Presse medicale (Paris, France : 1983) 20100101
-
Crossing borders: factors affecting differences in cost-effectiveness of smoking cessation interventions between European countries.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101
-
The cost-effectiveness of an extended course (12+12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20100101
-
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.
PharmacoEconomics 20100101
-
[Medications for smoking cessation. New advice concerning important neuropsychiatric effects].
Perspective infirmiere : revue officielle de l'Ordre des infirmieres et infirmiers du Quebec 20100101
-
Non smoking for successful aging: therapeutic perspectives.
Current pharmaceutical design 20100101
-
Varenicline for smokeless tobacco dependence.
Journal of postgraduate medicine 20100101
-
[More or less smoked news].
Pneumologia (Bucharest, Romania) 20100101
-
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial.
BMJ (Clinical research ed.) 20100101
-
Prescription drugs associated with reports of violence towards others.
PloS one 20100101
-
Smoking cessation in patients with chronic kidney disease.
CANNT journal = Journal ACITN 20100101
-
Varenicline and suicide. Safety data from New Zealand.
BMJ (Clinical research ed.) 20091231
-
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
European journal of public health 20091201
-
Sibutramine for weight gain attenuation during smoking cessation with varenicline: a pilot study.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20091201
-
A retrospective poison center review of varenicline-exposed patients.
The Annals of pharmacotherapy 20091201
-
Varenicline and antiretroviral therapy in patients with HIV.
Journal of acquired immune deficiency syndromes (1999) 20091201
-
Varenicline and suicide. Risk of psychiatric side effects with varenicline.
BMJ (Clinical research ed.) 20091201
-
Smoking cessation agents and suicide.
BMJ (Clinical research ed.) 20091105
-
Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans.
Psychopharmacology 20091101
-
What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20091101
-
[Drug treatment of tobacco dependence].
Deutsche medizinische Wochenschrift (1946) 20091101
-
Population pharmacokinetic analysis of varenicline in adult smokers.
British journal of clinical pharmacology 20091101
-
Nicotine dependence and smoking cessation.
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20091101
-
Varenicline-induced acute generalized exanthematous pustulosis.
Clinical and experimental dermatology 20091001
-
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.
Biochemical pharmacology 20091001
-
Smoking cessation: how to advise the patient.
Heart (British Cardiac Society) 20091001
-
Acute generalized exanthematous pustulosis caused by varenicline.
Journal of the European Academy of Dermatology and Venereology : JEADV 20090901
-
Acute hepatic injury associated with varenicline in a patient with underlying liver disease.
The Annals of pharmacotherapy 20090901
-
Varenicline increases striatal dopamine D(2/3) receptor binding in rats.
Addiction biology 20090901
-
Varenicline in prevention of relapse to smoking: effect of quit pattern on response to extended treatment.
Addiction (Abingdon, England) 20090901
-
Lambert-Eaton myasthenic syndrome following varenicline (Chantix) use.
Muscle & nerve 20090901
-
Varenicline in the management of smoking cessation: a single technology appraisal.
Health technology assessment (Winchester, England) 20090901
-
Varenicline gets stronger warnings about psychiatric problems, vehicle crashes.
JAMA 20090826
-
Safety of smoking cessation drugs.
The Medical letter on drugs and therapeutics 20090824
-
Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring.
Therapeutic advances in respiratory disease 20090801
-
Varenicline reduces alcohol self-administration in heavy-drinking smokers.
Biological psychiatry 20090715
-
Varenicline: a novel pharmacotherapy for smoking cessation.
Drugs 20090709
-
Varenicline augmentation in depressed smokers: an 8-week, open-label study.
The Journal of clinical psychiatry 20090701
-
Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.
Pharmacology & therapeutics 20090701
-
Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats.
Neuropharmacology 20090701
-
Worsening psychosis induced by varenicline in a hospitalized psychiatric patient.
Pharmacotherapy 20090701
-
Varenicline overdose in a teenager--a clinical pharmacology perspective.
Clinical toxicology (Philadelphia, Pa.) 20090701
-
Varenicline-induced mixed mood and psychotic episode in a patient with Schizoaffective Disorder.
CNS spectrums 20090701
-
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting.
Journal of substance abuse treatment 20090601
-
Does varenicline induce acute interstitial nephritis?
Mayo Clinic proceedings 20090601
-
Varenicline and proximal myopathy.
The Medical journal of Australia 20090601
-
Tobacco use among individuals with intellectual or developmental disabilities: a brief review.
Intellectual and developmental disabilities 20090601
-
Subjective improvement in proprioception in 2 patients with atypical Friedreich ataxia treated with varenicline (Chantix).
Journal of clinical neuromuscular disease 20090601
-
[Current and future medical drugs for smoking cessation].
Laryngo- rhino- otologie 20090601
-
Cost-effectiveness of varenicline for smoking cessation.
Expert review of pharmacoeconomics & outcomes research 20090601
-
Smoking-cessation therapy using varenicline: the cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence.
Journal of evaluation in clinical practice 20090601
-
Varenicline reduced smoking behaviour in a mentally ill person.
Journal of psychopharmacology (Oxford, England) 20090501
-
Persistent genital arousal disorder: a case report in a woman with lifelong PGAD where serendipitous administration of varenicline tartrate resulted in symptomatic improvement.
The journal of sexual medicine 20090501
-
Mood, side-effects and smoking outcomes among persons with and without probable lifetime depression taking varenicline.
Journal of general internal medicine 20090501
-
Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder.
Schizophrenia research 20090501
-
Combination treatment with varenicline and nicotine replacement therapy.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20090501
-
Safety and effectiveness of varenicline in a veteran population with a high prevalence of mental illness.
The Annals of pharmacotherapy 20090501
-
Hallucinations in the context of varenicline withdrawal.
The American journal of psychiatry 20090501
-
Reduced affective symptoms during tobacco dependence treatment with varenicline.
Addiction (Abingdon, England) 20090501
-
Do the 10 UK suicides among those taking the smoking cessation drug varenicline suggest a causal link?
Addiction (Abingdon, England) 20090501
-
Treatment of comorbid tobacco use in people with serious mental illness.
Journal of psychiatry & neuroscience : JPN 20090501
-
Chantix-induced mental status changes in a young healthy female.
South Dakota medicine : the journal of the South Dakota State Medical Association 20090501
-
Findings on alcohol dependence point to promising avenues for targeted therapies.
JAMA 20090422
-
The relevance and treatment of cue-induced cravings in tobacco dependence.
Journal of substance abuse treatment 20090401
-
The smoking cessation medication varenicline attenuates alcohol and nicotine interactions in the rat mesolimbic dopamine system.
The Journal of pharmacology and experimental therapeutics 20090401
-
Smoking in pregnancy and lactation: a review of risks and cessation strategies.
European journal of clinical pharmacology 20090401
-
Varenicline for smoking cessation: a placebo-controlled, randomized study.
Respirology (Carlton, Vic.) 20090401
-
Varenicline overdose in a teenager.
Clinical toxicology (Philadelphia, Pa.) 20090401
-
The pharmacokinetic and tolerability profile of varenicline in healthy Chinese volunteers.
International journal of clinical pharmacology and therapeutics 20090401
-
Two recent updates for psychiatric conditions.
Journal of child and adolescent psychopharmacology 20090401
-
Update on smoking cessation therapies.
Advances in therapy 20090401
-
Real world study to evaluate the effectiveness of varenicline and cognitive-behavioural interventions for smoking cessation.
International journal of environmental research and public health 20090401
-
Smoking cessation: aspects of prevention and therapy. The activity of the Smoking Cessation Center of Parma-Italy.
Acta bio-medica : Atenei Parmensis 20090401
-
Studies linking smoking-cessation drug with suicide risk spark concerns.
JAMA 20090311
-
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect.
European journal of pharmacology 20090301
-
Smoking cessation with varenicline: a suicidal fatality.
Journal of analytical toxicology 20090301
-
Varenicline and bupropion sustained-release combination therapy for smoking cessation.
Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco 20090301
-
Emerging drugs for the treatment of tobacco dependence.
Expert opinion on emerging drugs 20090301
-
Varenicline: a first-line treatment option for smoking cessation.
Clinical therapeutics 20090301
-
Antismoking drug still recommended to Canadians despite side effects and US advisory.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20090217
-
Varenicline for tobacco dependence.
The New England journal of medicine 20090212
-
Varenicline for tobacco dependence.
The New England journal of medicine 20090212
-
A 51-year-old woman with bipolar disorder who wants to quit smoking.
JAMA 20090204
-
Treatment of imbalance with varenicline Chantix(R): report of a patient with fragile X tremor/ataxia syndrome.
Acta neurologica Scandinavica 20090201
-
An algorithm for tailoring pharmacotherapy for smoking cessation: results from a Delphi panel of international experts.
Tobacco control 20090201
-
Interventions for preventing weight gain after smoking cessation.
The Cochrane database of systematic reviews 20090121
-
Varenicline improves mood and cognition during smoking abstinence.
Biological psychiatry 20090115
-
Budgetary impact of varenicline in smoking cessation in the United Kingdom.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101
-
Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.
Pharmacology, biochemistry, and behavior 20090101
-
Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics.
Annual review of pharmacology and toxicology 20090101
-
[Modern medical support for smoking cessation].
Der Internist 20090101
-
Update in new medications for primary care.
Journal of general internal medicine 20090101
-
Targeting reward-relevant nicotinic receptors in the discovery of novel pharmacotherapeutic agents to treat tobacco dependence.
Nebraska Symposium on Motivation. Nebraska Symposium on Motivation 20090101
-
New findings on nicotine addiction and treatment.
Nebraska Symposium on Motivation. Nebraska Symposium on Motivation 20090101
-
Quitting smoking without a psychotic break: the potential link between nicotinic acetylcholine receptor partial agonists and neuropsychiatric adverse events.
Clinical nurse specialist CNS 20090101
-
Do implementation issues influence the effectiveness of medications? The case of nicotine replacement therapy and bupropion in UK Stop Smoking Services.
BMC public health 20090101
-
[Varenicline - pharmacological therapy of tobacco dependence].
Wiener medizinische Wochenschrift (1946) 20090101
-
A preliminary benefit-risk assessment of varenicline in smoking cessation.
Drug safety 20090101
-
Pharmacokinetics, safety, and tolerability of varenicline in healthy adolescent smokers: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study.
Clinical therapeutics 20090101
-
Cost-utility analysis of varenicline, an oral smoking-cessation drug, in Japan.
PharmacoEconomics 20090101
-
Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient.
The Journal of neuropsychiatry and clinical neurosciences 20090101
-
Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century.
International journal of environmental research and public health 20090101
-
Safety and drug utilization profile of varenicline as used in general practice in England: interim results from a prescription-event monitoring study.
Drug safety 20090101
-
Varenicline-induced mania in a bipolar patient.
Clinical neuropharmacology 20090101
-
[Cardiac arrest with varenicline: a case report].
Therapie 20090101
-
Treating tobacco dependence in a medical setting.
CA: a cancer journal for clinicians 20090101
-
Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Clinical drug investigation 20090101
-
Varenicline and suicidal behaviour: a cohort study based on data from the General Practice Research Database.
BMJ (Clinical research ed.) 20090101
-
[A multidisciplinary approach of nicotine addiction--the new face of the tabaccology conference. IaÅŸi, June 25-27, 2009].
Pneumologia (Bucharest, Romania) 20090101
-
Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
Pneumologia (Bucharest, Romania) 20090101
-
Regulation of smoking cessation drugs by the Food and Drug Administration.
Food and drug law journal 20090101
-
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity.
International journal of chronic obstructive pulmonary disease 20090101
-
Varenicline: for smoking cessation.
Kathmandu University medical journal (KUMJ) 20090101
-
Evaluation of cost-utility of varenicline compared with existing smoking cessation therapies in South Korea.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090101
-
Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment.
The pharmacogenomics journal 20081201
-
Effect of varenicline on the acute and repeated locomotor responses to nicotine in rats.
Synapse (New York, N.Y.) 20081201
-
Varenicline-associated acute renal failure.
The Annals of pharmacotherapy 20081201
-
Possible varenicline-induced paranoia and irritability in a patient with major depressive disorder, borderline personality disorder, and methamphetamine abuse in remission.
Journal of clinical psychopharmacology 20081201
-
[Drug treatment for smoking and marijuana abuse].
Revue des maladies respiratoires 20081201
-
[Specific program for smoking cessation: thus your patients become nonsmokers].
MMW Fortschritte der Medizin 20081113
-
Varenicline for tobacco dependence.
The New England journal of medicine 20081106
-
Lack of a pharmacokinetic interaction between a new smoking cessation therapy, varenicline, and digoxin in adult smokers.
European journal of clinical pharmacology 20081101
-
The influence of acute varenicline administration on smoking and eating behavior in humans.
Pharmacology, biochemistry, and behavior 20081101
-
Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines.
International journal of clinical practice 20081101
-
Smoking cessation in pregnancy.
Expert opinion on drug safety 20081101
-
Smoking cessation: new ways to quit.
Harvard men's health watch 20081101
-
Suicidal ideation and varenicline: a possible case of mistaken adverse drug reaction?
The Journal of clinical psychiatry 20081101
-
Varenicline and smokers with mental illnesses.
Lancet (London, England) 20081004
-
Nicotinic receptor partial agonists as novel compounds for the treatment of smoking cessation.
Expert opinion on investigational drugs 20081001
-
Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice.
Behavioral neuroscience 20081001
-
Pharmacotherapy for smoking cessation.
Therapeutic advances in respiratory disease 20081001
-
[Varenicline for smoking cessation].
Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20080911
-
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080901
-
Drugs for tobacco dependence.
Treatment guidelines from the Medical Letter 20080901
-
The risk-benefit balance of varenicline for smoking cessation.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 20080901
-
Varenicline and suicidality: a new era in medication safety surveillance.
Expert opinion on drug safety 20080901
-
First in class.
Scientific American 20080901
-
Smoking cessation: the psychiatrist's role.
Journal of psychiatry & neuroscience : JPN 20080901
-
Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial.
Thorax 20080801
-
Varenicline efficacy and tolerability in a subject with schizophrenia.
Schizophrenia research 20080801
-
The place of varenicline in smoking cessation treatment.
Thorax 20080801
-
Pre-cessation varenicline treatment vs post-cessation NRT: an uneven playing field.
Thorax 20080801
-
Clinically significant outcomes in smoking cessation.
Thorax 20080801
-
Tobacco smoking cessation management: integrating varenicline in current practice.
Vascular health and risk management 20080801
-
Nicotine receptor partial agonists for smoking cessation.
The Cochrane database of systematic reviews 20080716
-
Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20080715
-
Varenicline (Chantix) warnings: risk versus benefit.
The Medical letter on drugs and therapeutics 20080714
-
Varenicline ameliorates ethanol-induced deficits in learning in C57BL/6 mice.
Neurobiology of learning and memory 20080701
-
The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial.
Current medical research and opinion 20080701
-
Diffuse exanthema in a patient receiving varenicline.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080701
-
Clinical inquiries. What are the most effective ways you can help patients stop smoking?
The Journal of family practice 20080701
-
[Champix not suitable for elderly with depression].
Lakartidningen 20080701
-
[Cost effectiveness analysis of varenicline (Champix) for the treatment of smoking in Spain].
Anales de medicina interna (Madrid, Spain : 1984) 20080701
-
Updated US smoking cessation guideline advises counseling, combining therapies.
JAMA 20080618
-
Smoking cessation in pregnancy: why, how, and what next..
Clinical obstetrics and gynecology 20080601
-
Pharmacological effects of nicotine on norepinephrine metabolism in rat brown adipose tissue: relevance to nicotinic therapies for smoking cessation.
Toxicologic pathology 20080601
-
Exacerbation of recurrent depression as a result of treatment with varenicline.
The American journal of psychiatry 20080601
-
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression.
CNS spectrums 20080601
-
Which drug to be used in smoking cessation?
Polskie Archiwum Medycyny Wewnetrznej 20080601
-
Varenicline treatment for smokers with schizophrenia: a case series.
The Journal of clinical psychiatry 20080601
-
Smoking cessation therapy with varenicline.
International journal of chronic obstructive pulmonary disease 20080601
-
Varenicline as compared to bupropion in smoking-cessation therapy--cost-utility results for Sweden 2003.
Respiratory medicine 20080501
-
Varenicline may trigger severe hypoglycaemia in Type 1 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 20080501
-
Empowering dental hygienists: tobacco cessation resources.
International journal of dental hygiene 20080501
-
Varenicline for smoking cessation.
Drug and therapeutics bulletin 20080501
-
[The ABC of smoking cessation].
Medizinische Monatsschrift fur Pharmazeuten 20080501
-
New kid on the block: Chantix for smoking cessation.
Texas dental journal 20080501
-
Stat bite: Medicaid coverage of tobacco-dependence treatments.
Journal of the National Cancer Institute 20080402
-
N-methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet.
Journal of pharmaceutical sciences 20080401
-
Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study.
Clinical pharmacology and therapeutics 20080401
-
Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.
Psychopharmacology 20080401
-
Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
Clinical pharmacology and therapeutics 20080401
-
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Clinical pharmacology and therapeutics 20080401
-
Breaking away from a narrow prescribing protocol for medicinal nicotine.
Addiction (Abingdon, England) 20080401
-
Efficacy and safety of varenicline for smoking cessation.
The American journal of medicine 20080401
-
Drug addiction: a critical problem calling for novel solutions.
Clinical pharmacology and therapeutics 20080401
-
Smoking cessation 2008.
IDrugs : the investigational drugs journal 20080401
-
What's new in clinical pharmacology and therapeutics.
WMJ : official publication of the State Medical Society of Wisconsin 20080401
-
FDA warns of adverse events linked to smoking cessation drug and antiepileptics.
JAMA 20080312
-
Comment and reply: A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
Current medical research and opinion 20080201
-
Hypomania with agitation associated with varenicline use in bipolar II disorder.
The Annals of pharmacotherapy 20080201
-
Smoking cessation and lung cancer: oncology nurses can make a difference.
Seminars in oncology nursing 20080201
-
Varenicline: a new pharmaceutical approach to smoking cessation.
Nursing for women's health 20080201
-
Cost-effectiveness of varenicline compared with bupropion, NRT, and nortriptyline for smoking cessation in the Netherlands.
Current medical research and opinion 20080101
-
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness.
Addiction (Abingdon, England) 20080101
-
An update on therapeutics for tobacco dependence.
Expert opinion on pharmacotherapy 20080101
-
Smoking cessation--what works?
Australian family physician 20080101
-
Varenicline versus bupropion SR or placebo for smoking cessation: a pooled analysis.
American journal of health behavior 20080101
-
Cost-utility analysis of varenicline versus existing smoking cessation strategies using the BENESCO Simulation model: application to a population of US adult smokers.
PharmacoEconomics 20080101
-
Chantix.
Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses 20080101
-
Varenicline and its role in smoking cessation.
Preventive cardiology 20080101
-
Smoking cessation therapy considerations for patients with chronic kidney disease.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association 20080101
-
Systematic review and meta-analysis of combination therapy for smoking cessation.
Journal of the American Pharmacists Association : JAPhA 20080101
-
[Not smoking, essential for healthy lungs].
Pharmazie in unserer Zeit 20080101
-
Treatment of ataxia and imbalance with varenicline (chantix): report of 2 patients with spinocerebellar ataxia (types 3 and 14).
Clinical neuropharmacology 20080101
-
Smoking cessation in cardiovascular patients.
Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20080101
-
[Pharmacotherapy of smoking cessation with application of nicotine and nicotine free drugs].
Przeglad lekarski 20080101
-
Varenicline and adult ADHD.
The Journal of neuropsychiatry and clinical neurosciences 20080101
-
Varenicline, appetite, and weight reduction.
The Journal of neuropsychiatry and clinical neurosciences 20080101
-
A reader responds to 'Seven pharmacotherapies do promote smoking abstinence at 6 and 12 months'.
Medscape journal of medicine 20080101
-
A longer course of varenicline therapy improves smoking cessation rates.
Preventive cardiology 20080101
-
Which is the best primary medication for long-term smoking cessation--nicotine replacement therapy, bupropion or varenicline?
Expert opinion on pharmacotherapy 20071201
-
Treatment of tobacco dependence: integrating recent progress into practice.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20071120
-
[Varenicline--a new drug for smoking cessation].
Ugeskrift for laeger 20071119
-
[New drugs; varenicline].
Nederlands tijdschrift voor geneeskunde 20071110
-
Lack of pharmacokinetic and pharmacodynamic interactions between a smoking cessation therapy, varenicline, and warfarin: an in vivo and in vitro study.
Journal of clinical pharmacology 20071101
-
Smoking cessation: an overview of treatment options with a focus on varenicline.
Pharmacotherapy 20071101
-
Breaking the ties of nicotine dependence.
The Nurse practitioner 20071101
-
Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
Pharmacotherapy 20071001
-
Smoking cessation: tactics that make a big difference.
The Journal of family practice 20071001
-
A new medication for the worst addiction.
Current psychiatry reports 20071001
-
A second varenicline trial.
Current psychiatry reports 20071001
-
Varenicline as maintenance therapy.
Current psychiatry reports 20071001
-
Treating tobacco dependence in women.
Journal of women's health (2002) 20071001
-
The truth about smoking cessation.
The Johns Hopkins medical letter health after 50 20071001
-
The cost effectiveness of varenicline for smoking cessation.
Managed care interface 20071001
-
A call to action: new treatment options provide even more reasons to intervene in tobacco dependence.
Nature clinical practice. Cardiovascular medicine 20070901
-
[Varenicline].
Revue de l'infirmiere 20070901
-
An evaluation of the OECD 308 water/sediment systems for investigating the biodegradation of pharmaceuticals.
Environmental science & technology 20070815
-
Varenicline-induced manic episode in a patient with bipolar disorder.
The American journal of psychiatry 20070801
-
Exacerbation of schizophrenia by varenicline.
The American journal of psychiatry 20070801
-
Varenicline: progress in smoking cessation treatment.
Expert opinion on pharmacotherapy 20070801
-
Optimizing on smoke free legislation making the most of the opportunity.
British journal of community nursing 20070801
-
Smoking cessation: lessons learned from clinical trial evidence.
Current opinion in cardiology 20070701
-
Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation.
Trends in pharmacological sciences 20070701
-
Varenicline: the newest agent for smoking cessation.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070701
-
The pharmacist's role in tobacco cessation: overview and introduction to the series.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070701
-
New non-nicotine drug to help smoking cessation efforts.
Nursing times 20070601
-
Why choose varenicline (chantix) for smoking cessation treatment?
Issues in mental health nursing 20070601
-
Smoking cessation update.
South Dakota medicine : the journal of the South Dakota State Medical Association 20070601
-
[New smoking cessation preparations unsuitable in mental disorders].
Lakartidningen 20070601
-
How well does the new drug varenicline work for people who want to stop smoking?
The Harvard mental health letter 20070601
-
A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.
Clinical therapeutics 20070601
-
Efficacy and tolerability of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, in a 12-week, randomized, placebo-controlled, dose-response study with 40-week follow-up for smoking cessation in Japanese smokers.
Clinical therapeutics 20070601
-
Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.
Addictive behaviors 20070501
-
Comment: Oral varenicline for smoking cessation.
The Annals of pharmacotherapy 20070401
-
A double-blind study evaluating the long-term safety of varenicline for smoking cessation.
Current medical research and opinion 20070401
-
An employer-based cost-benefit analysis of a novel pharmacotherapy agent for smoking cessation.
Journal of occupational and environmental medicine 20070401
-
Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid.
Neuropharmacology 20070301
-
[The path from cigarettes--with support it works better].
Medizinische Monatsschrift fur Pharmazeuten 20070301
-
[Varenicline--a new drug for smoking cessation].
Medizinische Monatsschrift fur Pharmazeuten 20070301
-
The most addictive drug, the most deadly substance: smoking cessation tactics for the busy clinician.
Primary care 20070301
-
[Giving up smoking is crucial for COPD patients].
MMW Fortschritte der Medizin 20070222
-
Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat.
Psychopharmacology 20070201
-
Impact of pharmacometric reviews on new drug approval and labeling decisions--a survey of 31 new drug applications submitted between 2005 and 2006.
Clinical pharmacology and therapeutics 20070201
-
Drug approvals.
The Nurse practitioner 20070201
-
Varenicline for smoking cessation.
Expert review of neurotherapeutics 20070201
-
Varenicline: new treatment with efficacy in smoking cessation.
Drugs of today (Barcelona, Spain : 1998) 20070201
-
[Drug of the month. Varenicline (Champix)].
Revue medicale de Liege 20070201
-
[Champix has become a registered drug].
Orvosi hetilap 20070128
-
Nicotine receptor partial agonists for smoking cessation.
The Cochrane database of systematic reviews 20070124
-
Mechanism of varenicline (clinical ramifications): electron transfer and oxidative stress.
Medical hypotheses 20070101
-
Oral varenicline for smoking cessation.
The Annals of pharmacotherapy 20070101
-
Non-nicotinic therapies for smoking cessation.
Annual review of pharmacology and toxicology 20070101
-
A clinical imperative: assisting patients who smoke to reduce their risk of cardiovascular disease.
Preventive cardiology 20070101
-
Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.
Preventive cardiology 20070101
-
Maximizing smoking cessation in clinical practice: pharmacologic and behavioral interventions.
Preventive cardiology 20070101
-
[Tobacco use prevention and cessation in the dental practice].
Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia 20070101
-
Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
Cardiology in review 20070101
-
[Varenicline (Champix)].
Journal de pharmacie de Belgique 20070101
-
Alcohol history and smoking cessation in nicotine replacement therapy, bupropion sustained release and varenicline trials: a review.
Alcohol and alcoholism (Oxford, Oxfordshire) 20070101
-
Kicking butts: smoking cessation update.
Missouri medicine 20070101
-
[Varenicline: an aid to smoking cessation therapy].
Revue medicale de Bruxelles 20070101
-
[Varenicline--a new chance for smokers?].
Przeglad lekarski 20070101
-
Efficacy of varenicline for smoking cessation.
JAMA 20061206
-
Multiple-dose pharmacokinetics of the selective nicotinic receptor partial agonist, varenicline, in healthy smokers.
Journal of clinical pharmacology 20061201
-
Trials that matter: varenicline: a designer drug to help smokers quit.
Annals of internal medicine 20061121
-
Pharmacokinetics, safety, and tolerability after single and multiple oral doses of varenicline in elderly smokers.
Journal of clinical pharmacology 20061101
-
New prescription drug available to help smokers stop.
Mayo Clinic health letter (English ed.) 20061001
-
Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors.
Molecular pharmacology 20060901
-
Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.
Journal of clinical pharmacology 20060901
-
New weapon to curb smoking: no more excuses to delay treatment.
Archives of internal medicine 20060801
-
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
Archives of internal medicine 20060801
-
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
Archives of internal medicine 20060801
-
Varenicline (Chantix) for tobacco dependence.
The Medical letter on drugs and therapeutics 20060801
-
Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
JAMA 20060705
-
Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.
JAMA 20060705
-
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
JAMA 20060705
-
Varenicline for smoking cessation: definite promise, but no panacea.
JAMA 20060705
-
Varenicline.
Nature reviews. Drug discovery 20060701
-
The neurobiological basis for partial agonist treatment of nicotine dependence.
International journal of clinical practice 20060501
-
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.
International journal of clinical practice 20060501
-
Molecule of the Month. Varenicline tartrate.
Drug news & perspectives 20060401
-
Pharmacologic interventions for smoking cessation.
Critical care nursing clinics of North America 20060301
-
FDA speeds smoking cessation drug review.
JAMA 20060208
-
Metabolism and disposition of varenicline, a selective alpha4beta2 acetylcholine receptor partial agonist, in vivo and in vitro.
Drug metabolism and disposition: the biological fate of chemicals 20060101
-
New drugs: varenicline tartrate, insulin glulisine, and insulin detemir.
Journal of the American Pharmacists Association : JAPhA 20060101
-
Varenicline: a review of its use as an aid to smoking cessation therapy.
CNS drugs 20060101
-
Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.
BMC public health 20060101
-
[New tobacco dependence drug: Varenicline, partial agonist of alpha4beta2 acetylcholine-nicotine receptors].
Casopis lekaru ceskych 20060101
-
The FDA approves new drug for smoking cessation.
FDA consumer 20060101
-
Smoking cessation efficacy and safety of varenicline, an alpha4beta2 nicotinic receptor partial agonist.
The Journal of cardiovascular nursing 20060101
-
Varenicline (CHANTIX): a stop-smoking pill.
ORL-head and neck nursing : official journal of the Society of Otorhinolaryngology and Head-Neck Nurses 20060101
-
[Medication for ending tobacco dependency. Current state].
Atencion primaria 20050630
-
Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation.
Journal of medicinal chemistry 20050519
-
Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
Current medical research and opinion 20050501